Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2015, 24(5):315-320

Baroreflex sensitivity and resistant hypertension

Čelovská D1, Gonsorčík J2, Dukát A1, Gašpar Ľ1
1 1II. interná klinika LF UK a UN Bratislava, Nemocnica Staré Mesto, Bratislava
2 Východoslovenský ústav srdcových a cievnych chorôb, Košice a Kardiologická klinika UPJŠ, Košice, Slovenská republika

Aim: Baroreflex sensitivity is a noninvasive marker of autonomic nervous system integrity, which characterises efficacy of blood pressure regulation. The aim of study was to evaluate differences and clinical significance of baroreflex sensitivity in risk stratification of patients with primary, well controlled hypertension and resistant hypertension.

Patients and Methods: A total of 105 patients, 96 patients with primary hypertension (46 M/50 F, 68±9.54 years of age) and 9 patients with resistant hypertension (3M/6F, 64±5.86 years of age), were studied. The relationship between baroreflex sensitivity (BRS) and blood pressure, global cardiovascular risk and major cardiovascular (CV) events in hypertensives was assessed. BRS was determined by the sequence and spectral method, with controlled breathing protocol at a frequency of 0.1 Hz, during five-minute non-invasive beat-to-beat recording of blood pressure and R-R interval.

Results: We found significant negative correlation between spontaneous BRS and systolic BP values (-0.52, p<0.001). Spontaneous BRS values in hypertensives with major CV event (stroke, myocardial infarction) were significantly lower even 6 months and more after event onset compared to hypertensives without CV event (p<0.05). Patients with critical value of BRS ≤ 3 ms/mmHg (36 patients, 34.28%, 24M/12F) were mostly men with arterial hypertension and metabolic syndrome with BMI 32.46±3.4 kg/m2. 7(77.7%) patients with resistant hypertension had BRS ≤ 3 ms/mmHg. BRS values were significantly reduced in hypertensives with resistant hypertension compared to hypertensives (2.18±1.05 vs 5.92±2.51 ms/mmHg, p<0.001).

Conclusion: Arterial hypertension is associated with decreased BRS. Patients with resistant hypertension have significantly more often critical values BRS ≤ 3 ms/mmHg than other hypertensives. Reduced BRS value could be a potential predictor of baroreflex stimulation therapy response.

Keywords: baroreflex sensitivity; autonomic nervous system; arterial hypertension; resistant hypertension

Published: May 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čelovská D, Gonsorčík J, Dukát A, Gašpar Ľ. Baroreflex sensitivity and resistant hypertension. Cardiology Letters. 2015;24(5):315-320.
Download citation

References

  1. Grassi G, Seravalle G. Sympatho-vagal imbalance in hypertension. In: Robertson D, et al. Primer on the autonomic nervous system. Third Edition. San Diego, USA: Elsevier; 2012:345-348. Go to original source...
  2. Chapleau MW. Baroreceptor Reflexes. In: Robertson D, et al. Primer on the autonomic nervous system. Third Edition. San Diego, USA: Elsevier; 2012:161-165. Go to original source...
  3. Mancia G, Fegard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the managment of arterial hypertension. Journal of Hypertension 2013;31:1281-1357. Go to original source...
  4. Honzíková N, Lábrová R, Fišer B, et al. Influence of age, body mass index and blood pressure on the carotid-media thickness in normotensive and hypertensive patients. Biomed Tech 2006;51:159-162. Go to original source...
  5. Menne J, Jordan J, Linnenwebwr-Held S, et al. Resistant hypertension: baroreflex stimulation as a new tool. Nephrol Dial Transplant 2013;28:288-295. Go to original source...
  6. Parati G, Rienzo MD, Mancia G. How to measure baroreflex sensitivity: from cardiovascular laboratory to daily life. J Hypertens 2000;18:7-19. Go to original source...
  7. Ormezzano O, Cracowski JL, Quesada JL, et al. Evaluation of the prognostic values of baroreflex sensitivity in hypertensive patients: the EVABAR study. J Hypertens 2008;26:1373-1378. Go to original source...
  8. La Rovere MT, Bigger JT, Marcus FI, et al. Baroreflex sensitivity and heart variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998;351:478-484. Go to original source...
  9. Robinson TG, Dawson SL, Eames PJ, et al. Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke 2003;34:705-712. Go to original source...
  10. Čelovská D, Staško J, Gonsorčík J, et al. Klinický význam senzitivity baroreflexu u pacientov s artériovou hypertenziou. Cardiol 2009;18:99-107.
  11. Bilgutay AM, Lillehei CW. Treatment of hypertension with an implantable electronic device. JAMA 1965;191:649-653. Go to original source...
  12. Heusser K, Tank J, Engeli S, et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension. 2010;55:619-626. Go to original source...
  13. Scheffers IJM, Kroon AA, Schmidli J, et al. Novel Baroreflex Activation Therapy in Resistant Hypertension. J Am Coll Cardiol. 2010;56:1254-1258. Go to original source...
  14. Bignano JD,Bakris G, Nadim MK, et al. Baroreflex Activation Therapy Lowers Blood Pressure in Patients with Resistant Hypertension. J Am Coll Cardiol. 2011;58:765-773. Go to original source...
  15. Hasenfuss G. New Generation Barostim Neo System: preliminary results and discussion. ESC 2011 Barostim Symposium. 2011; Paris, France.
  16. Hoppe UC, Brandt MCh, Wachter R, et al. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile results from Barostin neo trial. J Am Coll Cardiol. 2012;59: E1784. Go to original source...
  17. Zuern CS., Christian E, Konstatinos D, et al. Impaired Cardiac Baroreflex Sensitivty Predicts response to Renal Sympathetic Denervation in Patients with resistant Hypertension. J Am Coll Cardiol 2013;62:2123-2130. Go to original source...
  18. Škultétyová D, Filipová S, Maďarič J, et al. Hodnotenie karotickej tuhosti prietokom navodenej dilatácie u pacientov s rezistentnou hypertenziou po renálnej denervácii sympatika. Cardiology Lett. 2014;23: 15-222.